MedTrace Logo

Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients

NCT05766488 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-09-30

No results posted yet for this study

Summary

Continuous glucose monitoring (CGM) has demonstrated improved outcomes in both type 1 and type 2 diabetes populations in comparison to traditional methods; however, these devices have not been well studied in underserved adult patients (e.g., low-income, uninsured) who may face additional barriers to monitoring. Furthermore, there is limited data exploring long-term (3- to 6- month) health care team-based management of these devices in the primary care setting. The purpose of this study is to further understand the benefits and barriers associated with CGM use in underserved populations with type 2 diabetes and improve their overall diabetes care.

Conditions

Interventions

DEVICE

Continuous Glucose Monitor (CGM)

A Freestyle Libre 2 continuous glucose monitor (CGM) will be provided in the experimental arm of this study for 6 months.

DEVICE

Self-monitoring Blood Glucose (SMBG)

A traditional glucometer device will be assigned in the active comparitor arm of this study for 6 months.

Sponsors & Collaborators

  • Great Plains IDeA-CTR

    collaborator UNKNOWN

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Drew C Prescott, PharmD · University of Nebraska

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-24
Primary Completion
2026-07-31
Completion
2026-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05766488 on ClinicalTrials.gov